BioDelivery Sciences International

Two opioid use disorder drug developments to watchNew physician-administered therapies on the horizon may help rein in the opioid epidemic.
Seven things to know about Express Scripts’ plan to limit opioidsAs President Trump declares the opioid epidemic “a national emergency,” a new opioid management program from Express Scripts will limit the number and strength of opioid drugs to first-time patients.
Fourteen things Trump needs to know about opioidsAs President Trump promises fight the opioid epidemic, here are 14 things experts want him to know.
Buccal buprenorphine approved for patients with chronic painFDA has approved buprenorphine (Belbuca, Endo Pharmaceuticals) buccal film for use in patients with chronic pain.
FDA approves new Onsolis formulationFDA has approved sNDA for new formulation of fentanyl buccal soluble film (Onsolis, BioDelivery Sciences International) CII for the management of breakthrough pain in patients with cancer who are opioid tolerant.
FDA drug approvals-July 2014FDA drug approvals, priority review, breakthrough designation, fast-track designations, orphan drug designations, first-time generic approval